Učitavanje...

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy

Although available data are conflicting, psoriasis seems to be associated with an increased baseline risk of malignancy. In addition, some antipsoriatic systemic treatments have been associated with risk of malignancy. There is not enough data on the association of interleukin (IL)-17 and IL-23 inhi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Case Rep Dermatol
Glavni autor: Gambardella, Alessio
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2019
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816125/
https://ncbi.nlm.nih.gov/pubmed/31662733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501993
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!